Makes contact lenses, eye drops and tools for eye surgery.
New: first time
Third Point bought Bausch + Lomb for the first time between April and June: 85,000 shares, worth about $1 million. That’s already less than $1 of every $100 they have in stocks.
Mar 31
None
Jun 30
85,000
The numbers
Shares they own
85,000
Value on Jun 30, 2026
$1,407,600
about $1 million
Share of their money
0.0%
less than $1 of every $100 · 31st of 35
Price per share on Jun 30
$16.56
Kind
Shares
Also owned by
No other fund we follow
More about Bausch + Lomb ›
The value uses the price on Jun 30, 2026. The fund may have paid a different price.